Epilansis: A NextGen, Cloud-based Epidemiology Platform for Faster, Smarter Market Decisions
With the healthcare landscape shifting rapidly, teams across biopharma, consulting, med-tech, and healthcare strategy face a common bottleneck: turning scattered epidemiology data, literature, real world data and competitive signals into clear, actionable insights. Epidemiology remains the backbone of clinical development, commercial planning, medical strategy, and portfolio decision-making but in most organizations, the data is still fragmented, inconsistent, or slow to update. EpiLansis, an AI-powered epidemiology and forecasting platform by Thelansis, was designed to address the pain points. Built for scientific, commercial, and strategy teams, EpiLansis brings together real-time epidemiology data, global disease burden matrix, potential patient funnel, treatment landscapes, patient journey analytics, and disease burden insights— all in one cloud-based environment. With 350+ indications, 35+ global markets, and a robust AI-driven research engine, the platform empowers teams to...